![]() |
The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients
Hyun Kyung Ryu, Ji Sun Baek, Woo Dae Kang, Seok Mo Kim
Obstet Gynecol Sci. 2015;58(5):368-376. Published online 2015 Sep 22 DOI: https://doi.org/10.5468/ogs.2015.58.5.368
|
Citations to this article as recorded by
Promising predictive molecular biomarkers for cervical cancer (Review)
Marcela Lizano, Adela Carrillo‑García, Erick De La Cruz‑Hernández, Leonardo Castro‑Muñoz, Adriana Contreras‑Paredes
International Journal of Molecular Medicine.2024;[Epub] CrossRef Contrast-enhanced ultrasound combined with elastic imaging for predicting the efficacy of concurrent chemoradiotherapy in cervical cancer: a feasibility study
Yujuan Ma, Xuebo Zhao, Xianxia Chen
Frontiers in Oncology.2024;[Epub] CrossRef The optimal threshold for squamous-cell carcinoma antigen to predict lymph node metastasis in early-stage cervical squamous-cell carcinoma
Xing-bo Chen, Wei-li Li, Chun-yan Tan, Ning Xu
Asian Journal of Surgery.2024; 47(9): 3909. CrossRef Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer
Ludivine Beaussire-Trouvay, Orianne Duhamel, Anne Perdrix, Emilie Lévêque, Roman Vion, Anne Rovelet-Lecrux, Nasrin Sarafan-Vasseur, Frédéric Di Fiore, Agathe Crouzet, Marianne Leheurteur, Florian Clatot
Frontiers in Oncology.2024;[Epub] CrossRef Role of squamous cell carcinoma antigen (SCC-Ag) in the management of carcinoma cervix in an Indian population: A pilot study
Sankalp Singh, Arti Sarin, Mayuri Jain, Abhishek Purkayastha, Divya Shelly, Niharika Bisht
Medical Journal Armed Forces India.2024;[Epub] CrossRef To Predict the Efficacy of Concurrent Chemoradiotherapy for Advanced Cervical Cancer by CT Perfusion Imaging
凯芸 徐
Advances in Clinical Medicine.2024; 14(09): 1199. CrossRef Advances in Squamous Cell Carcinoma Antigen and Cervix Cancer Relationship
Bashar H. Hamoud, Dragoș E. Georgescu, Amalia L. Călinoiu, Ileana A. Văcăroiu, Mihai T. Georgescu
Romanian Journal of Military Medicine.2023; 126(1): 10. CrossRef Significantly higher serum levels and positive rates of tumor biomarkers in patients with oral lichen planus
Yu-Hsueh Wu, Chun-Pin Chiang
Journal of Dental Sciences.2023; 18(3): 1288. CrossRef Role of squamous cell carcinoma antigen in prognostication, monitoring of treatment response, and surveillance of locally advanced cervical carcinoma
Vinitha Tony, Arvind Sathyamurthy, Jeba Karunya Ramireddy, S. Janani Iswarya, S Mahasampath Gowri, Anitha Thomas, Abraham Peedicayil, Thomas Samuel Ram
Journal of Cancer Research and Therapeutics.2023; 19(5): 1236. CrossRef Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
Yi Huang, Fangfang Liu, Ruiping Xu, Fuyou Zhou, Wenlei Yang, Yu He, Zhen Liu, Bolin Hou, Linlin Liang, Lixin Zhang, Mengfei Liu, Yaqi Pan, Ying Liu, Zhonghu He, Yang Ke
Frontiers in Oncology.2023;[Epub] CrossRef Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
Wenjuan Chen, Siyi Xiu, Xingyun Xie, Huiming Guo, Yuanji Xu, Penggang Bai, Xiaoyi Xia
Radiation Oncology.2022;[Epub] CrossRef Squamous Cell Carcinoma Antigen: Clinical Application and Research Status
Huange Zhu
Diagnostics.2022; 12(5): 1065. CrossRef Association of pretreatment SUVmax of cervix and SCC‐antigen with FIGO2018 stage in Stage IIB–IVB squamous cervical cancer and relationship to prognosis
Huafeng Shou, Yoshioka Yasuo, Shuhui Yuan, Hanmei Lou, Juan Ni
International Journal of Gynecology & Obstetrics.2021; 152(1): 112. CrossRef Serum levels and positive rates of tumor biomarkers in oral precancer patients
Yu-Hsueh Wu, Ping-Yi Lin, Ju-Hsuan Yang, Ying-Shiung Kuo, Yang-Che Wu
Journal of the Formosan Medical Association.2021; 120(6): 1324. CrossRef Significantly higher serum tumor marker levels in patients with oral submucous fibrosis
Yu-Hsueh Wu, Ping-Yi Lin, Ju-Hsuan Yang, Ying-Shiung Kuo, Yang-Che Wu, Chun-Pin Chiang
Journal of Dental Sciences.2021; 16(3): 846. CrossRef Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group
Virginia Benito, Amina Lubrano, José F. Pérez-Regadera, Aureli Torné, Antonio Gil-Moreno, Álvaro Tejerizo-Garcia, Ramona Vergés, Berta Díaz-Feijoo
Gynecologic Oncology.2021; 162(2): 407. CrossRef Higher serum homocysteine level and frequency of hyperhomocysteinemia in carcinoembryonic antigen-positive or squamous cell carcinoma-antigen-positive oral leukoplakia patients
Yu-Hsueh Wu, Ping-Yi Lin, Ju-Hsuan Yang, Ying-Tai Jin, Yang-Che Wu
Journal of the Formosan Medical Association.2021; 120(12): 2128. CrossRef Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis
Sea-Won Lee, Ji Hyung Hong, Mina Yu, Songmi Jeong, Sung Hwan Kim, Yeon-Sil Kim, Sung Jong Lee, Jong Hoon Lee
Clinical & Experimental Metastasis.2021; 38(5): 467. CrossRef Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study
Yoko Harima, Takuro Ariga, Yuko Kaneyasu, Hitoshi Ikushima, Sunao Tokumaru, Shigetoshi Shimamoto, Takeo Takahashi, Noriko Ii, Kayoko Tsujino, Anneyuko I. Saito, Hiroki Ushijima, Takafumi Toita, Tatsuya Ohno, Stephanie Markovina
PLOS ONE.2021; 16(11): e0259235. CrossRef Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Maximilian Fleischmann, Georgios Chatzikonstantinou, Emmanouil Fokas, Jörn Wichmann, Hans Christiansen, Klaus Strebhardt, Claus Rödel, Nikolaos Tselis, Franz Rödel
Cancers.2021; 13(22): 5748. CrossRef Predictive value of preoperative serum squamous cell carcinoma antigen (SCC–Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study
Qinhao Guo, Jun Zhu, Yong Wu, Hao Wen, Lingfang Xia, Xiaohua Wu, Xingzhu Ju
European Journal of Surgical Oncology.2020; 46(1): 131. CrossRef The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study
Shuang Ye, Xiaohua Sun, Bin Kang, Fei Wu, Zhong Zheng, Libing Xiang, Mylène Lesénéchal, Fabienne Heskia, Ji Liang, Huijuan Yang
BMC Cancer.2020;[Epub] CrossRef Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy
Yan Xu, Lijing Zhu, Li Zhu, Huanhuan Wang, Tong Ru, Baorui Liu, Jian He, Sibo Tian, Zhengyang Zhou, Xiaofeng Yang
European Radiology.2020; 30(1): 471. CrossRef Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
Peng Chen, Liang Jiao, Fang Ren, Dan-Bo Wang
BMC Cancer.2020;[Epub] CrossRef Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors
Xiaomin Zheng, Weiqian Guo, Jiangning Dong, Liting Qian
Magnetic Resonance Imaging.2020; 72: 159. CrossRef Prognostic Role of Squamous Cell Carcinoma Antigen in Cervical Cancer: A Meta-analysis
Zhenhua Liu, Hongtai Shi
Disease Markers.2019; 2019: 1. CrossRef The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Jingxuan Fu, Weiping Wang, Yidan Wang, Chengeng Liu, Peichang Wang
Radiation Oncology.2019;[Epub] CrossRef Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
Weiping Wang, Xiaoliang Liu, Xiaorong Hou, Xin Lian, Zhikai Liu, Jie Shen, Shuai Sun, Junfang Yan, Zheng Miao, Dunhuang Wang, Qinggyu Meng, Jingxuan Fu, Fuquan Zhang, Jie Qiu, Ke Hu
Gynecologic Oncology.2019; 155(2): 224. CrossRef Cervical Cancer Markers: Epigenetics and microRNAs
Vishuda Laengsri, Usanee Kerdpin, Chotiros Plabplueng, Lertyot Treeratanapiboon, Pornlada Nuchnoi
Laboratory Medicine.2018; 49(2): 97. CrossRef The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis
Chuenkamon Charakorn, Kunlawat Thadanipon, Sawarat Chaijindaratana, Sasivimol Rattanasiri, Pawin Numthavaj, Ammarin Thakkinstian
Gynecologic Oncology.2018; 150(1): 190. CrossRef Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance
Jinju Oh, Jin Young Bae
Obstetrics & Gynecology Science.2018; 61(3): 337. CrossRef GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
Fei Ouyang, Junling Liu, Meng Xia, Chuyong Lin, Xianqiu Wu, Liping Ye, Libing Song, Jun Li, Jing Wang, Peng Guo, Mian He
Oncology Reports.2017; 37(5): 2652. CrossRef Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer
Wei Jiang, Jia-Jia Pan, Ying-Hui Deng, Mei-Rong Liang, Li-Hua Yao
Journal of Gynecologic Oncology.2017;[Epub] CrossRef The comparison of Architect SCC and cobas SCC tests
Ewa Wójcik, Krzysztof Reinfuss, Zofia Stasik, Urszula Rychlik, Jadwiga Tarapacz, Jan K. Kulpa
Diagnostyka Laboratoryjna.2017; 53(3): 147. CrossRef
|